Nektar Therapeutics
Pharmaceuticals
Company overview
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. The company is developing rezpegaldesleukin, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 2b clinical trial to treat atopic dermatitis and psoriasis; and NKTR-255, an IL-15 receptor agonist, which is in phase 1 clinical trial to boost the immune system's natural ability to fight cancer. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. The company was incorporated in 1990 and is headquartered in San Francisco, California.
Employees by Level
C-Level
8
VP-Level
35
Director
145
Manager
150
Non-Manager
318
Top Contacts
381
Available Jobs at Nektar Therapeutics
Top C-suite Members of Company
Connect with key decision-makers at Nektar Therapeutics. View the C-suite executives and leadership team.
| Name | Title | Contact | Action |
|---|---|---|---|
| Howard Robin | President & Chief Executive Officer | h****[email protected] | Show details |
| Jillian Thomsen | Senior VP, Finance & Chief Accounting Officer | j****[email protected] | Show details |
| Bowers Parker | Associate Controller | b****[email protected] | Show details |
| Bill Fahey | Controller | b****[email protected] | Show details |
| Jason Barnard | Vice President & Corporate Controller | j****[email protected] | Show details |
| John Alstrom | Corporate Controller | j****[email protected] | Show details |
| Lorin Sasaki | Vice President, Financial Planning & Analysis | l****[email protected] | Show details |
| Bill Fahey | Controller | b****[email protected] | Show details |
| Michelle Ryder | Vice President, Regulatory Affairs | m****[email protected] | Show details |
| Bowers Parker | Associate Controller | b****[email protected] | Show details |
| Angeline Tan | Vice President, Research & Development Qualit | a****[email protected] | Show details |
| Carlo Di Fonzo | Product Safety Vice President, Regulatory Aff | c****[email protected] | Show details |
| Takahiro Miyazaki | Head Senior VP, Research | t****[email protected] | Show details |
Employees Contact
Connect with company employees using the separately sourced, masked contact dataset.
Email formats
Discover the professional email patterns used at Nektar Therapeutics.
| Email format | Example | Percentage |
|---|---|---|
| Email formats for Nektar Therapeutics are not available. | ||
Email verification tool
Find and verify professional email addresses for Nektar Therapeutics.
Technology stack
Nektar Therapeutics uses Open Graph to enhance their digital capabilities and improve operational efficiency.
Nektar Therapeutics uses HTTP/3 to enhance their digital capabilities and improve operational efficiency.
Nektar Therapeutics uses ShareThis to enhance their digital capabilities and improve operational efficiency.
Nektar Therapeutics uses Twitter Emoji (Twemoji) to enhance their digital capabilities and improve operational efficiency.
Nektar Therapeutics uses jsDelivr to rapidly serve web assets like JavaScript libraries and CSS frameworks from a global content delivery network, enhancing website speed, reliability, and ease of development.
Nektar Therapeutics uses Google Cloud CDN to enhance their digital capabilities and improve operational efficiency.
Nektar Therapeutics uses DoubleClick Floodlight to enhance their digital capabilities and improve operational efficiency.
Nektar Therapeutics uses Google Tag Manager to efficiently deploy and manage website tracking tags, marketing pixels, and analytics scripts without direct code modifications, centralizing data collection and accelerating marketing and analytics initiatives.
Nektar Therapeutics uses Splide to enhance their digital capabilities and improve operational efficiency.
Nektar Therapeutics uses jQuery Migrate to ensure backward compatibility and smooth upgrades to newer jQuery versions by restoring deprecated features and behaviors, preventing existing scripts from breaking and aiding in code modernization.
Nektar Therapeutics uses jQuery to simplify client-side scripting, enabling faster and more efficient manipulation of the HTML DOM, event handling, animation, and AJAX interactions across various web browsers.
Nektar Therapeutics uses core-js to enhance their digital capabilities and improve operational efficiency.
Nektar Therapeutics uses Nginx to enhance their digital capabilities and improve operational efficiency.
Nektar Therapeutics uses Google Cloud to enhance their digital capabilities and improve operational efficiency.
Nektar Therapeutics uses Vimeo to professionally host, manage, and share high-quality video content, enabling secure distribution, enhanced collaboration, and insightful analytics for diverse business and creative purposes.
Nektar Therapeutics uses PHP to develop dynamic, data-driven web applications and websites, leveraging its robust server-side scripting capabilities for powerful and scalable online experiences.
Nektar Therapeutics uses MySQL to store, manage, and retrieve structured data efficiently and reliably, powering scalable web applications and critical business operations with robust data management capabilities.
Nektar Therapeutics uses WordPress to enhance their digital capabilities and improve operational efficiency.